Wednesday, August 10, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

Adverse Events After Simultaneous COVID-19 mRNA Booster, Flu Vaccination

by Global Biodefense Staff
July 16, 2022
Adverse Events After Simultaneous COVID-19 mRNA Booster, Flu Vaccination

A corpsman screens a patient prior to administering vaccinations at Walter Reed National Medical Center. Credit: Elizabeth Kearns

Are systemic reactions more common after simultaneous administration of COVID-19 mRNA booster and seasonal influenza vaccines than after COVID-19 mRNA booster alone?

Findings from this study suggest that simultaneous administration of COVID-19 mRNA booster and influenza vaccines may be associated with a slightly increased likelihood of systemic reactions.

Self-reported data from 981,099 persons aged 12 years or older given simultaneous administration of a COVID-19 mRNA booster dose and an influenza vaccine was associated with 8% to 11% increases, respectively, in systemic reaction compared with COVID-19 mRNA booster alone.

In both groups, most reactions reported in the week following vaccination were generally mild.

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US. JAMA Network Open, 15 July 2022.


Read also:

Perspective: More (mostly mild) side effects when flu vaccine given with COVID booster. CIDRAP

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines. The Lancet Respiratory Medicine

Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey. Journal of Personalized Medicine

Immunogenicity of third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: An open question. Human Vaccines & Immunotherapeutics

COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy. Pharmaceuticals

Comments on vaccine coadministration – 21st Meeting of the European Technical Advisory Group of Experts on Immunization (‎ETAGE) – Nov 2021‎. World Health Organization

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. The Lancet Respiratory Medicine

Tags: COVID-19Editor PickInfluenzaSARS-CoV-2Vaccines

Related Posts

Influenza Transmission Spikes During Social Gatherings
Medical Countermeasures

New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections

July 17, 2022
Poxvirus Proteins Enable Early Strike on Immune Defences
Pathogens

Poxvirus Proteins Enable Early Strike on Immune Defences

July 15, 2022
US Starts Clinical Trial for mRNA Nipah Virus Vaccine
Medical Countermeasures

US Starts Clinical Trial for mRNA Nipah Virus Vaccine

July 11, 2022
Targeting Poxviruses with Messenger RNA Technology
Medical Countermeasures

Targeting Poxviruses with Messenger RNA Technology

July 11, 2022
Load More

Latest News

Bacteria That Causes Melioidosis Confirmed in Environmental Samples in Mississippi Gulf Coast

Bacteria That Causes Melioidosis Confirmed in Environmental Samples in Mississippi Gulf Coast

July 27, 2022
Monkeypox Transmission: Virus Detected in Saliva, Bodily Fluids

Monkeypox Transmission: Virus Detected in Saliva, Bodily Fluids

July 17, 2022
Influenza Transmission Spikes During Social Gatherings

New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections

July 17, 2022
Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19

Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19

July 17, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC